
51 - 200 funcionários
Fundada em 1993
🏥 Saúde
💼 Consultoria
🍽️ Alimentos e Bebidas
💰 $35.000.000 Grant em 2023-01
Healthcare • Consulting • Food & Beverage
O Instituto de Vacinas Sabin se dedica a melhorar a saúde global, garantindo o acesso a vacinas que salvam vidas. O instituto foca em pesquisa e desenvolvimento de novas vacinas para algumas das doenças mais urgentes do mundo, incluindo cólera, HPV, malária, Marburg e Ebola. Através de programas e parcerias inovadoras, a Sabin busca melhorar as capacidades de imunização e a aceitação de vacinas dentro das comunidades, esforçando-se para tornar a vacinação acessível a todos, especialmente às populações vulneráveis.
🕒 Outubro 9
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $250.000 - $315.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
👻 Score fantasma 0%
🗣️🇺🇸🇬🇧 Inglês obrigatório
Melhore suas chances de conseguir uma entrevista verificando sua pontuação de currículo antes de se candidatar.

51 - 200 funcionários
Fundada em 1993
🏥 Saúde
💼 Consultoria
🍽️ Alimentos e Bebidas
💰 $35.000.000 Grant em 2023-01
Healthcare • Consulting • Food & Beverage
O Instituto de Vacinas Sabin se dedica a melhorar a saúde global, garantindo o acesso a vacinas que salvam vidas. O instituto foca em pesquisa e desenvolvimento de novas vacinas para algumas das doenças mais urgentes do mundo, incluindo cólera, HPV, malária, Marburg e Ebola. Através de programas e parcerias inovadoras, a Sabin busca melhorar as capacidades de imunização e a aceitação de vacinas dentro das comunidades, esforçando-se para tornar a vacinação acessível a todos, especialmente às populações vulneráveis.
• Develop and execute a roadmap to mature the phase-appropriate QMS across GMP, GCP, GVP, and GLP • Advise executive leadership on quality, compliance, inspection readiness, and risk management • Embed quality culture across functions, partners, and development programs • Own quality governance, metrics, escalation pathways, management review, and quality risk management frameworks • Provide senior leadership for GMP quality activities supporting vaccine development, technology transfer, process validation, PPQ, commercial readiness, and lifecycle management • Oversee GCP quality systems, clinical-development audits, inspection readiness, vendor oversight, and quality risk management • Oversee GVP quality activities, including adverse-event reporting, signal management, aggregate safety reporting, and regulatory compliance • Oversee GLP-related quality activities supporting nonclinical studies • Establish and approve quality agreements and oversee risk-based qualification, auditing, monitoring, and requalification of GxP partners • Ensure partner responsibilities, escalation and reporting requirements, audit and data-access rights, change and deviation notification, CAPA management, inspection support, and remediation • Provide quality oversight for validated GxP systems, document and data governance, records retention, data integrity, and remote-inspection capabilities • Partner with IT on cybersecurity and business-continuity requirements for GxP systems • Lead inspection readiness and serve as sponsor quality lead for FDA BIMO, PAIs, surveillance inspections, and other health authority inspections • Direct critical investigations involving serious breaches, safety or data-integrity concerns, manufacturing deviations, or systemic quality failures • Ensure GxP documentation and quality systems are complete, controlled, inspection-ready, and aligned with FDA, EMA, ICH, WHO, and other expectations • Identify and escalate quality risks and drive mitigation • Recruit, develop, mentor, and retain Quality professionals • Contribute quality content to INDs, BLAs, MAAs, health-authority responses, and related regulatory submissions • Provide Quality leadership for funding proposals and due-diligence activities
• Bachelor’s degree in a relevant scientific, engineering, quality, or related field • At least 16 years of progressively responsible quality experience in biologics development and manufacturing • Experience with vaccines, viral vectors, or similarly complex biologics strongly preferred • Proven people-leadership experience and success driving organizational change, preferably in a small biotechnology and/or virtual organization • Experience serving on an R&D or executive leadership team preferred • Demonstrated success developing or substantially transforming a QMS in preparation for late-stage development and licensure • Direct experience supporting late-stage clinical development, process validation, PPQ, PAI readiness, and BLA/MAA submissions • Experience leading health authority inspections and interacting with FDA and other global regulatory agencies • Expert knowledge of GMP, GCP, GLP, and GVP requirements; relevant ICH guidelines, including ICH E6(R3), E8, E9, Q9, and Q10; and applicable FDA, EMA, MHRA, WHO, and other global regulatory expectations • Demonstrated experience establishing sponsor oversight and quality governance across outsourced development and manufacturing networks, including CDMOs, CROs, and contract laboratories • Broad understanding of interdependencies among nonclinical development, translational science, Phase 3 clinical operations, pharmacovigilance, biostatistics and data management, CMC, regulatory strategy, and quality • Ability to identify and mitigate cross-functional risks to licensure • Ability to lead collaboratively across technical functions, external partners, geographic regions, and matrixed teams • Strong judgment, problem-solving, and interpersonal skills • Experience supporting U.S. government-funded projects preferred • Must demonstrate interest in furthering Sabin’s mission • Subject to a criminal background investigation • Three professional references required • Verification of education/degrees • Must be authorized to work in the United States without employer sponsorship • Not eligible for visa sponsorship
• Medical, dental, and vision coverage • Flexible spending accounts • Flexible vacation leave • Sick leave • Short-term disability options • Long-term disability options • 10 federal holidays • End-of-year winter break • Employer matching 401(k) plan
Candidatar-se🕒 Outubro 9
Vice President leading pharmacometrics consulting, scientific teams, and business development. Simulations Plus accelerates pharmaceutical development through model-informed and AI-powered software and consulting.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $250.000 - $300.000 / ano
💰 Grant - Simulations Plus em 2024-11
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Outubro 9
Capital markets executive leading tax equity, preferred equity, and debt financing for Pivot Energy’s renewable energy and storage projects. Overseeing origination, negotiations, team leadership, and enterprise capital strategy.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $220.000 - $275.000 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Outubro 9
Vice President leading provider network strategy, recruiting, credentialing, and readiness. Strengthening Leidos QTC’s medical examination and health services delivery across customer programs.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $218.991 - $2.962.834 / ano
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Outubro 9
Vice President of Product leading strategy, roadmaps, and product teams for Onfleet’s last-mile delivery platform. Driving enterprise growth, adoption, and cross-functional planning.
🇺🇸 Estados Unidos – Remoto (EUA)
💵 $175.000 - $225.000 / ano
💰 $23.000.000 Series B em 2022-06
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🦅 Patrocina Visto H1B
🗣️🇺🇸🇬🇧 Inglês obrigatório
🕒 Outubro 8
Vice President leading enterprise sales for TeamViewer’s digital workplace platform in the Southeast USA. Driving regional strategy, revenue growth, team performance, and customer expansion.
🇺🇸 Estados Unidos – Remoto (EUA)
💰 Series unknown em 2009-02
⏰ Tempo Integral
🔴 Especialista
👔 Vice-presidente
🗣️🇺🇸🇬🇧 Inglês obrigatório